In GM-CSF, the haplotype AAGAGCGAA was also associated with a decreased overall breast cancer risk (OR 0.92, 95 % CI 0.87–0.96, p value = 2.7 × 10−4, Table 6). Here, CSF2 is linked to breast cancer.